SignatureFD’s Pfizer PFE Stock Holding History

SignatureFD’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.32M	Buy	118,371 +7,679	+7%	+$204K	0.05%	143
2025 Q4	$2.76M	Buy	110,692 +5,532	+5%	+$140K	0.04%	168
2025 Q3	$2.68M	Buy	105,160 +6,171	+6%	+$152K	0.04%	171
2025 Q2	$2.4M	Buy	98,989 +9,912	+11%	+$231K	0.04%	172
2025 Q1	$2.26M	Buy	89,077 +9,454	+12%	+$247K	0.04%	165
2024 Q4	$2.11M	Sell	79,623 -37,464	-32%	-$1.02M	0.04%	165
2024 Q3	$3.39M	Buy	117,087 +4,562	+4%	+$133K	0.06%	106
2024 Q2	$3.15M	Buy	112,525 +23,440	+26%	+$645K	0.06%	107
2024 Q1	$2.47M	Sell	89,085 -4,272	-5%	-$119K	0.05%	132
2023 Q4	$2.69M	Sell	93,357 -51,510	-36%	-$1.56M	0.06%	113
2023 Q3	$4.81M	Buy	144,867 +27,635	+24%	+$977K	0.13%	62
2023 Q2	$4.3M	Buy	117,232 +7,642	+7%	+$297K	0.11%	67
2023 Q1	$4.47M	Sell	109,590 -7,387	-6%	-$319K	0.12%	61
2022 Q4	$5.99M	Buy	116,977 +12,153	+12%	+$583K	0.18%	44
2022 Q3	$4.59M	Sell	104,824 -5,552	-5%	-$270K	0.16%	48
2022 Q2	$5.79M	Buy	110,376 +7,090	+7%	+$361K	0.2%	40
2022 Q1	$5.35M	Buy	103,286 +3,268	+3%	+$170K	0.16%	48
2021 Q4	$5.91M	Buy	100,018 +10,544	+12%	+$522K	0.18%	44
2021 Q3	$3.85M	Buy	89,474 +3,624	+4%	+$161K	0.13%	57
2021 Q2	$3.36M	Buy	85,850 +3,568	+4%	+$139K	0.13%	58
2021 Q1	$2.98M	Buy	82,282 +34	+0%	+$1.21K	0.13%	63
2020 Q4	$3.03M	Sell	82,248 -13,612	-14%	-$499K	0.14%	48
2020 Q3	$3.34M	Buy	95,860 +14,188	+17%	+$497K	0.18%	42
2020 Q2	$2.53M	Buy	81,672 +5,550	+7%	+$189K	0.15%	48
2020 Q1	$2.36M	Sell	76,122 -25,032	-25%	-$853K	0.2%	43
2019 Q4	$3.76M	Buy	101,154 +47,437	+88%	+$1.69M	0.28%	33
2019 Q3	$1.83M	Sell	53,717 -8,588	-14%	-$312K	0.15%	51
2019 Q2	$2.56M	Buy	62,305 +2,233	+4%	+$88.7K	0.22%	37
2019 Q1	$2.42M	Sell	60,072 -7,604	-11%	-$305K	0.21%	38
2018 Q4	$2.8M	Buy	67,676 +2,436	+4%	+$101K	0.26%	32
2018 Q3	$2.73M	Buy	65,240 +7,269	+13%	+$280K	0.28%	34
2018 Q2	$2M	Buy	57,971 +12,003	+26%	+$410K	0.22%	46
2018 Q1	$1.55M	Buy	45,968 +3,501	+8%	+$120K	0.18%	42
2017 Q4	$1.46M	Buy	42,467 +8,865	+26%	+$302K	0.18%	51
2017 Q3	$1.14M	Buy	33,602 +1,722	+5%	+$55.3K	0.15%	46
2017 Q2	$1.02M	Sell	31,880 -8,230	-21%	-$260K	0.15%	52
2017 Q1	$1.3M	Buy	40,110 +13,769	+52%	+$434K	0.19%	40
2016 Q4	$812K	Sell	26,341 -1,064	-4%	-$32.5K	0.14%	56
2016 Q3	$881K	Buy	27,405 +4,366	+19%	+$146K	0.13%	56
2016 Q2	$770K	Buy	23,039 +8,178	+55%	+$261K	0.11%	47
2016 Q1	$418K	Sell	14,861 -390	-3%	-$11.1K	0.07%	85
2015 Q4	$467K	Buy	15,251 +2,657	+21%	+$83.6K	0.09%	66
2015 Q3	$375K	Buy	12,594 +1,061	+9%	+$34K	0.09%	77
2015 Q2	$367K	Buy	11,533 +1,330	+13%	+$43.3K	0.08%	94
2015 Q1	$337K	Buy	10,203 +2,773	+37%	+$88.2K	0.08%	95
2014 Q4	$220K	Buy	7,430 +625	+9%	+$17.9K	0.05%	118
2014 Q3	$191K	Buy	6,805 +3,021	+80%	+$84.8K	0.06%	124
2014 Q2	$107K	Buy	3,784 +720	+23%	+$20.5K	0.04%	166
2014 Q1	$93K	Sell	3,064 -3,263	-52%	-$97.3K	0.04%	127
2013 Q4	$184K	Sell	6,327 -1,132	-15%	-$32.9K	0.07%	90
2013 Q3	$203K	Buy	7,459 +2,694	+57%	+$73.3K	0.09%	74
2013 Q2	$127K	Buy	+4,765	New	+$132K	0.07%	105

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SignatureFD's PFE Position: Q1 2026 in Review

SignatureFD increased its Pfizer (PFE) stake by 6.9% in Q1 2026, buying an estimated $204K and bringing the position to 118,371 shares worth $3.32M. The position accounts for 0.05% of the portfolio, ranked #143.

SignatureFD first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.99M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

SignatureFD held 118,371 shares of Pfizer worth $3.32M as of Q1 2026.
SignatureFD bought 7,679 Pfizer shares in Q1 2026, an estimated $204K.
Pfizer made up 0.05% of SignatureFD's portfolio in Q1 2026, its #143 holding.
SignatureFD first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
SignatureFD's Pfizer position peaked at $5.99M in Q4 2022.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.